Rejection and Recurrence: Analyzing Complications of a Two-Time Deceased Donor Kidney Transplant Pediatric Recipient (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0799; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "6 years later, a biopsy on the transplanted kidney revealed findings consistent with Ab-mediated rejection, and the patient was prescribed solumedrol, IVIG, and a one-time dose of rituximab...Following treatment of Albumin with lasix IV, she experienced fluid overload and was immediately diuresed...Ultimately, the recurrence of MPGN II acted as the irreversible driver of graft failure. Upon receiving the second kidney transplant, the patient was started on Eculizumab to prevent early complement activation and mitigate the risk of disease recurrence in the allograft, suggesting that preventative management is important in DDD management."
Clinical • Cardiovascular • Complement-mediated Rare Disorders • Epstein-Barr Virus Infections • Glomerulonephritis • Hypertension • Lupus Nephritis • Nephrology • Pediatrics • Rare Diseases • Transplantation
|
|
Ashley Kuo; Rain H. Wong; Evan Schneider; Sohum Bhargava; Dylan Oest; Nayeli Rodriguez-Martinez; Anjay Rastogi
|